TABLETTE

Patent europeic · EP3220896 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3220896
Numer da la dumonda
EP15797175
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
16-11-2015
Publitgà
27-09-2017
Concedì
27-05-2026
La protecziun finescha il pli tard
15-11-2035
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61K 31/137 (2006.01)
A61K 31/343 (2006.01)
A61K 31/155 (2006.01)
A61P 3/10 (2006.01)
A61P 31/10 (2006.01)
A61K 9/20 (2006.01)
A61P 9/02 (2006.01)
Prioritad
GB 201420300 14.11.2014
Dumonda PCT
PCT/GB2015/053473 16.11.2015
Publicaziun PCT
WO2016/075497 19.05.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 26-08-2026

    Represchentant inscrit

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 26.08.2026

  2. 27-05-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 27.05.2026

Partidas

Possessur

Drug Delivery International Ltd

Basement Medical Block Within Glasgow Royal Infirmary 84 Castle Street, Glasgow, Strathclyde G4 0SF, GB

Represchentant

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventur

STEVENS, Howard Norman Ernest

Larkhall Strathclyde ML9 3BN, GB

MULLEN, Alexander Balfour

East Kilbride Strathclyde G74 2HE, GB

MACDOUGALL, Fiona Jane

Bishopbriggs Strathclyde G64 1ET, GB

ORDOYNO, Claire Helen

Glasgow Strathclyde G12 9SP, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.